SYNLAB AG
SYNLAB AG provides medical diagnostic services and specialty testing services for hospitals, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. SYNLAB AG was founded in 1998 and is based in Munich, Germany.
SYNLAB AG (SYAB) - Net Assets
Latest net assets as of March 2024: €2.37 Billion EUR
Based on the latest financial reports, SYNLAB AG (SYAB) has net assets worth €2.37 Billion EUR as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.71 Billion) and total liabilities (€2.34 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.37 Billion |
| % of Total Assets | 50.35% |
| Annual Growth Rate | 24.8% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 40.37 |
SYNLAB AG - Net Assets Trend (2020–2023)
This chart illustrates how SYNLAB AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SYNLAB AG (2020–2023)
The table below shows the annual net assets of SYNLAB AG from 2020 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €2.34 Billion | +0.21% |
| 2022-12-31 | €2.33 Billion | +3.44% |
| 2021-12-31 | €2.26 Billion | +87.42% |
| 2020-12-31 | €1.20 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to SYNLAB AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 35495500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €3.14 Billion | 134.14% |
| Total Equity | €2.34 Billion | 100.00% |
SYNLAB AG Competitors by Market Cap
The table below lists competitors of SYNLAB AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Datamatics Global Services Limited
NSE:DATAMATICS
|
$125.49 Million |
|
TWOWAY Communications, Inc.
TW:8045
|
$125.50 Million |
|
Sam Yung Tradi
KO:002810
|
$125.59 Million |
|
Copperbank Resources Corp
OTCQX:CPPKF
|
$125.70 Million |
|
Jiangshan Oupai Door Industry Co Ltd
SHG:603208
|
$125.47 Million |
|
Banvida
SN:BANVIDA
|
$125.47 Million |
|
ASOS Plc
PINK:ASOMF
|
$125.44 Million |
|
Auswide Bank Ltd
AU:ABA
|
$125.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SYNLAB AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 2,333,171,000 to 2,340,398,000, a change of 7,227,000 (0.3%).
- Net income of 92,274,000 contributed positively to equity growth.
- Dividend payments of 76,934,000 reduced retained earnings.
- New share issuances of 203,000 increased equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €92.27 Million | +3.94% |
| Dividends Paid | €76.93 Million | -3.29% |
| Share Issuances | €203.00K | +0.01% |
| Other Changes | €-8.32 Million | -0.36% |
| Total Change | €- | 0.31% |
Book Value vs Market Value Analysis
This analysis compares SYNLAB AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.21x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.38x to 1.21x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | €5.43 | €12.93 | x |
| 2021-12-31 | €10.16 | €12.93 | x |
| 2022-12-31 | €10.62 | €12.93 | x |
| 2023-12-31 | €10.65 | €12.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SYNLAB AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.94%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.50%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 1.99x
- Recent ROE (3.94%) is below the historical average (14.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 21.36% | 9.83% | 0.50x | 4.38x | €137.00 Million |
| 2021 | 27.68% | 16.59% | 0.69x | 2.40x | €399.08 Million |
| 2022 | 6.46% | 4.64% | 0.60x | 2.31x | €-82.62 Million |
| 2023 | 3.94% | 3.50% | 0.57x | 1.99x | €-141.77 Million |
Industry Comparison
This section compares SYNLAB AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SYNLAB AG (SYAB) | €2.37 Billion | 21.36% | 0.99x | $125.49 Million |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| Global Bioenergies SA (1DK) | $14.81 Million | -86.04% | 0.89x | $369.68K |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| 2invest AG (2INV) | $82.61 Million | -2.29% | 0.06x | $13.67 Million |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |